Literature DB >> 11142705

Fungal infections in the immunocompromised host.

B Wanke1, M dos S Lazéra, M Nucci.   

Abstract

In recent years many remarkable changes occurred in our way of life, producing opportunities for microbes. All these changes are related to the recent emergence of previously unrecognized diseases, or the resurgence of diseases that, at least in developed countries, were thought to be under control. This concept is reviewed regarding fungal infections and their agents in the immunocompromised host. The changing pattern of these infections, the portals of entry of fungi into the human host, fungal pathogenicity and the main predisposing factors are analyzed. Opportunistic fungal infections in cancer, organ transplant and acquired immunodeficiency syndrome patients are reviewed, specially candidiasis and aspergillosis.

Entities:  

Mesh:

Year:  2000        PMID: 11142705     DOI: 10.1590/s0074-02762000000700025

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3.

Authors:  Yu Liu; George Tortora; Maria E Ryan; Hsi-Ming Lee; Lorne M Golub
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience.

Authors:  Ravinder Kaur; Bhanu Mehra; Megh Singh Dhakad; Ritu Goyal; Preena Bhalla; Richa Dewan
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 3.  Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.

Authors:  Juliana Alves Parente-Rocha; Alexandre Melo Bailão; André Correa Amaral; Carlos Pelleschi Taborda; Juliano Domiraci Paccez; Clayton Luiz Borges; Maristela Pereira
Journal:  Mediators Inflamm       Date:  2017-06-13       Impact factor: 4.711

4.  Portal Dissemination of Fusarium graminearum in a Patient with Acute Lymphoblastic Leukemia and Febrile Neutropenia.

Authors:  Mary Gabriela Uscamayta; Alexandra Martin-Onraet; Karla Espinosa-Bautista; Roberto Herrera-Goepfert; Rigoberto Hernández-Castro; Carolina Perez-Jimenez
Journal:  Infect Dis Rep       Date:  2021-01-01

5.  In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs.

Authors:  Kamiar Zomorodian; Azadeh Bandegani; Hossein Mirhendi; Keyvan Pakshir; Navvab Alinejhad; Ali Poostforoush Fard
Journal:  Jundishapur J Microbiol       Date:  2016-02-20       Impact factor: 0.747

6.  The Plant Defensin NaD1 Enters the Cytoplasm of Candida Albicans via Endocytosis.

Authors:  Brigitte M E Hayes; Mark R Bleackley; Marilyn A Anderson; Nicole L van der Weerden
Journal:  J Fungi (Basel)       Date:  2018-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.